Wix Announces 20 Workforce Reduction Amid AIDriven Restructuring
Nio Shares Surge 10 on Launch of First Flagship EV in More Than Two Years
Mortgage Rate Outlook Bond Market Movements May Hold the Key
Guzman y Gomez Shares Surge on Decision to Exit US Market and Refocus on Australia
Gold Under Pressure Bearish Momentum Builds as Potential Test of 4444 Comes into Focus
Morgan Stanley Adjusts Price Target for Jazz Pharmaceuticals
Conduent CNDT Q1 2026 Earnings Earnings Surprise Lifts Shares Amid Turnaround Efforts
Weibo WB Q3 2025 Earnings EPS of 042 as Stock Edges Higher Amid Unclear Revenue Picture
SSSSL Q1 2026 Earnings Massive EPS Beat Driven by Investment Gains Notes Unchanged
OSS Q1 2026 Earnings Surprise Profitability Despite Revenue Uncertainty
MongoDB Inc MDB Q1 2026 Earnings EPS Beat Drives Positive Stock Reaction
Seagate Technology STX Q1 2026 Earnings Strong EPS Beat Drives Stock Higher
Independent Bank Corp INDB Holds Steady Near Key Support Amid Modest Uptick
PetMed Express PETS Faces Continued Pressure Amid 36 Decline Testing Key Support Levels
Talen Energy TLN Slips 24 as Traders Weigh Key Support and Resistance Levels
Flaherty Crumrine Total Return Fund FLC Holds Steady Near Key Support as YieldSeeking Investors Weigh Options
Cencora Inc COR Surges 357 as Stock Approaches Key Resistance
Consumer Prices Rise 38 in April Exceeding Expectations and Marking Highest Inflation Since May 2023
RIVN Q1 2026 Earnings NarrowerThanExpected Loss Highlights Cost Discipline
Equus Total Return Inc EQS Moves Higher as Price Approaches Key Resistance
YSS Q1 2026 Earnings EPS Misses Estimates by Wide Margin as PreRevenue Stage Continues
Omada Health Q1 2026 Earnings Narrower Loss Beat Estimates as Company Focuses on Operational Efficiency
VLGEA Q1 2025 Earnings Reported EPS of 086 Amid Quiet Investor Response
GWRE Q1 2026 Earnings Strong EPS Beat Drives Positive Market Reaction
ACCS Q1 2026 Earnings EPS Misses Estimates Amid Operational Challenges
BRBS Q1 2026 Earnings Positive EPS Surprise Amid Market Headwinds
KURA Q1 2026 Earnings WiderthanExpected Loss Highlights ClinicalStage Biotechs Cash Burn